Article
Phenotype-specific therapeutic efficacy of ilofotase alfa in patients with sepsis-associated acute kidney injury.
Critical care (London, England) - 19 Feb 2024
Bruse Niklas, Pardali Katerina, Kraan Maarten, Kox Matthijs, Pickkers Peter
Abstract excerpt
BACKGROUND: There is no effective treatment for sepsis-associated acute kidney injury (SA-AKI). Ilofotase alfa (human recombinant alkaline phosphatase) has been shown to exert reno-protective properties, although it remains unclear which patients might be most likely to benefit. We aimed to identify a clinical phenotype associated with ilofotase alfa's therapeutic efficacy. METHODS: Data from 570 out of 650...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
